Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Goodwill (2020 - 2025)

Northwest Biotherapeutics' Goodwill history spans 6 years, with the latest figure at $626000.0 for Q4 2025.

  • Quarterly results put Goodwill at $626000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $626000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $626000.0, changed 0.0%.
  • Goodwill for Q4 2025 was $626000.0 at Northwest Biotherapeutics, roughly flat from $626000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $626000.0 in Q1 2021 to a low of $626000.0 in Q1 2021.
  • The 5-year median for Goodwill is $626000.0 (2021), against an average of $626000.0.
  • Peak annual rise in Goodwill hit 0.0% in 2021, while the deepest fall reached 4.28% in 2021.
  • Year by year, Goodwill stood at $626000.0 in 2021, then changed by 0.0% to $626000.0 in 2022, then changed by 0.0% to $626000.0 in 2023, then changed by 0.0% to $626000.0 in 2024, then changed by 0.0% to $626000.0 in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $626000.0, $626000.0, and $626000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.